:

DEEPSEEK CHASES AGI WITH $10B FUNDING ROUND

INDUSTRY DESK2 MIN READ
FRI, MAY 22, 2026

■ AI-SUMMARIZED FROM 5 SOURCES ▸ TIMELINE

DeepSeek's leadership is pitching investors on an AGI-focused strategy for its 70 billion yuan ($10 billion) funding round, prioritizing long-term AI research over near-term commercial gains.

DeepSeek has told potential investors backing its $10 billion funding round that the Chinese AI startup will emphasize fundamental research toward artificial general intelligence rather than immediate commercialization efforts. The messaging signals a strategic shift in how the company plans to deploy capital at a critical moment in its development. Senior management outlined plans to concentrate resources on breakthrough AI research capabilities, according to people with knowledge of investor discussions. The funding round, valued at 70 billion yuan, represents a substantial capital injection for the startup. The approach mirrors strategies taken by other major AI labs that have historically balanced research ambitions with commercial applications. DeepSeek has gained attention for releasing open-source AI models and competitive offerings that challenge incumbents in the space. The company's commitment to research-first priorities suggests it views the funding as an opportunity to strengthen its technical foundations rather than accelerate market expansion. This positioning comes as the broader AI industry grapples with questions about sustainable paths to AGI. Many companies face investor pressure to demonstrate near-term returns, making DeepSeek's stated research focus noteworthy. The startup's investors have historically supported aggressive R&D spending. The $10 billion round appears designed to extend that runway significantly as DeepSeek pursues increasingly complex AI capabilities. The company's trajectory reflects intensifying competition in AI development, particularly among well-funded teams racing toward more capable systems. DeepSeek's AGI-focused messaging to investors indicates leadership confidence in its technical direction and long-term viability in a crowded market.

■ SOURCES

TechmemeThe DecoderBloomberg TechHacker NewsBloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

12H AGOAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

12H AGOAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

20H AGOAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.